Relias Media - Continuing Medical Education Publishing

The trusted source for

healthcare information and

CONTINUING EDUCATION.

  • Sign In
  • Sign Out
  • MyAHC
    • Home
      • Home
      • Newsletters
      • Blogs
      • Archives
      • CME/CE Map
      • Shop
    • Emergency
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Hospital
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Clinical
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • All Access
      • Subscribe Now
      • My Subscription
    • My Account
      • My Subscriptions
      • My Content
      • My Orders
      • My CME/CE
      • My Transcript
    Home » Submentalis REM Sleep Muscle Activity: A Potential Biomarker for Synucleinopathy
    ABSTRACT & COMMENTARY

    Submentalis REM Sleep Muscle Activity: A Potential Biomarker for Synucleinopathy

    January 1, 2020
    No Comments
    Reprints
    Facebook Twitter Linkedin Share Share

    Related Articles

    REM Sleep, Not Slow-wave Sleep, Decreases Dementia Risk

    LPA as a Potential Biomarker for Ovarian and Other Gynecologic Cancers

    The Relationship Between REM Sleep Behavioral Events and Parkinson’s Disease

    Related Products

    REM Behavior Disorder — A Unique Window into the Mysteries of Neurodegenerative Disease

    Functional MRI in REM Behavior Disorder Is Suggestive of Future Parkinson’s Disease

    How Much More Physical Activity Helps Patients Avoid Chronic Diseases?

    Keywords

    sleep

    parkinsonism

    synucleinopathy

    rswa

    By Daniel A. Barone, MD, FAASM

    Assistant Attending Neurologist, NewYork-Presbyterian Hospital, and Assistant Professor of Clinical Neurology, Weill Cornell Medical College

    Dr. Barone reports he is on the speakers bureau for Jazz Pharmaceuticals and is a consultant for Molecule Mattress.

    SYNOPSIS: Objective findings during polysomnography (REM sleep without atonia), as diagnosed with submentalis EMG recordings, may be a biomarker for synucleinopathies, such as Parkinson’s disease and multiple system atrophy.

    SOURCE: McCarter SJ, Feemster JC, Tabatabai GM, et al. Submentalis rapid eye movement sleep muscle activity: A potential biomarker for synucleinopathy. Ann Neurol 2019;86:969-974.

    Parkinson’s disease (PD), multiple system atrophy (MSA), progressive supranuclear palsy (PSP), and corticobasal degeneration (CBD), grouped as “parkinsonism” syndromes, often have overlapping symptoms, which can complicate diagnosis. This is unfortunate because the prediction of treatment response, prognostic counseling, and use of disease-modifying therapy rely on such accuracy. Currently, diagnosis of parkinsonism is based on clinical evaluation with limited biomarkers.

    Tau accumulation is associated with PSP and CBD (so-called tauopathies), whereas alpha-synuclein accumulation is associated with PD and MSA (so-called synucleinopathies). Rapid eye movement (REM) sleep behavior disorder (RBD) consists of a history of dream enactment behavior (DEB) in conjunction with REM sleep without atonia (RSWA) noted during polysomnography (PSG) testing. RBD strongly correlates with alpha-synucleinopathy, but much less with tauopathies. Despite this clear difference, clinical DEB is not specific for parkinsonism etiology. Thus, the authors aimed to determine whether quantitative RSWA testing distinguishes probable synucleinopathy and tauopathy subtypes of parkinsonism, using electromyographic (EMG) analysis in the submentalis and anterior tibialis muscles in parkinsonian patients.

    The authors analyzed RSWA in 97 patients at the Mayo Clinic between 2008 and 2015. Patient groups included 53 probable synucleinopathy patients (meeting clinical diagnostic criteria for PD [n = 33] and MSA [n = 20]) and 24 probable tauopathy patients (meeting clinical criteria for PSP [n = 17] or CBD [n = 7]). These groups were analyzed against 20 age- and sex-matched controls. Of note, while both visual scoring (by standard American Academy of Sleep Medicine standards) and automated scoring (via HypnoLab software) were used and compared, the automated scoring method demonstrated more cases of RSWA and was more precise in that it allowed for a REM atonia index (RAI).

    Comparing RAI across the four parkinsonian conditions, elevated submentalis EMG activity was highly sensitive (70-77%) and specific (95-100%) in distinguishing synucleinopathy from tauopathy, whereas with anterior tibialis EMG, synucleinopathy discrimination was poor. The authors concluded that elevated submentalis EMG activity in RSWA appears to be a potentially useful biomarker for presumed synucleinopathy etiologies in parkinsonism.

    COMMENTARY

    With this paper, the authors have opened a new door for further research into RSWA and RBD, an ever-growing subset of neurology and sleep medicine. The authors mentioned that among the 97 patients, the use of quantitative scoring demonstrated more cases of RSWA than qualitative scoring by visual inspection, and there was poor correlation between the quantitative and qualitative methods. This is important, as often in clinical practice, RSWA typically is scored through visual inspection and thus, per this study, may be missed. Perhaps in the future, automated/universal scoring of EMG (especially in REM sleep) will allow for more uniform data analysis, with positive implications for both clinical and research endeavors.

    Another element worth discussing is that in clinical practice, isolated RSWA without DEB is considered a PSG finding of unclear significance. The authors compared RSWA in cases both with and without DEB, and found the association that RSWA can distinguish synucleinopathy from tauopathy regardless of DEB. This finding adds to the growing literature that suggests that isolated RSWA may be a harbinger of synucleinopathy and requires further investigation.

    Post a comment to this article

    Report Abusive Comment

    www.reliasmedia.com

    Neurology Alert

    View PDF
    Neurology Alert (Vol. 39, No. 5) - January 2020
    January 1, 2020

    Table Of Contents

    Significance of Brain Microbleeds After Traumatic Brain Injury

    Neuropathology and Dementia in Football Players With CTE

    Fluctuating Cognition: An Often-Neglected Feature of Lewy Body Dementias

    Submentalis REM Sleep Muscle Activity: A Potential Biomarker for Synucleinopathy

    Stereotactic Radiosurgery for the Treatment of Cerebral Cavernous Malformations

    Does a Repeat Course of IVIg Help in Severe Guillain-Barré Syndrome?

    Begin Test

    Buy this Issue/Course

    Financial Disclosure: Neurology Alert’s Editor in Chief Matthew Fink, MD; Peer Reviewer M. Flint Beal, MD; Editorial Group Manager Leslie Coplin; Editor Jason Schneider; Executive Editor Shelly Morrow Mark; and Accreditations Manager Amy M. Johnson, MSN, RN, CPN, report no financial relationships relevant to this field of study.

    Shop Now: Search Products

    • Subscription Publications
    • Books & Study Guides
    • Webinars
    • Group & Site
      Licenses
    • State CME/CE
      Requirements

    Webinars And Events

    View All Events
    • Home
      • Home
      • Newsletters
      • Blogs
      • Archives
      • CME/CE Map
      • Shop
    • Emergency
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Hospital
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Clinical
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • All Access
      • Subscribe Now
      • My Subscription
    • My Account
      • My Subscriptions
      • My Content
      • My Orders
      • My CME/CE
      • My Transcript
    • Help
    • Search
    • About Us
    • Sign In
    • Register
    Relias Media - Continuing Medical Education Publishing

    The trusted source for

    healthcare information and

    CONTINUING EDUCATION.

    Customer Service

    customerservice@reliasmedia.com

    U.S. and Canada: 1-800-688-2421

    International +1-404-262-5476

    Accounts Receivable

    1-800-370-9210
    ReliasMedia_AR@reliasmedia.com

    Mailing Address

    • 1010 Sync St., Suite 100
      Morrisville, NC 27560-5468
      USA

    © 2020 Relias. All rights reserved.

    Do Not Sell My Personal Information  Privacy Policy  Terms of Use  Contact Us  Reprints  Group Sales

    For DSR inquiries or complaints, please reach out to Wes Vaux, Data Privacy Officer, DPO@relias.com

    Design, CMS, Hosting & Web Development :: ePublishing